The report includes breast cancer epidemiology including global and regional prevalence, incidence and mortality rates; regulatory environment for markers and therapeutics along with recent regulatory approvals, current and new technologies, market projections and market share for key market player
The breast cancer diagnostic and drug technology markets include a variety of products approved for breast cancer treatment, including hormonal therapies, chemotherapeutic drugs, combinations and targeted therapies. Many side effects, adverse reactions and safety concerns have come up associated with newer, innovative drugs.
Therefore, drugs with improved safety and efficacy are needed to treat breast cancer effectively.
Key Companies mentioned in this research: AbbVie Inc., Array BioPharma Inc., AstraZeneca, Belrose Pharmaceuticals, Beta Pharma, BioMarin Pharmaceuticals, CASI Pharmaceuticals, Inc., Celgene, Celldex Therapeutics, Celsion, Clovis, Clovis Eli Lilly, ovartis, Pfizer, Puma Biotechnology, Roche, Syndax Pharmaceuticals and Tesaro Inc.
Access premium sample for free: www.ingeniousreports.com/Breast-Ca…es-Global-Markets .
- 36 data tables and 47 additional tables
- Country specific data and analysis for United States, Canada, Mexico, UK, France, Germany, Italy, China, India, Japan, and South Korea
- Estimated revenue of the global mammography, biopsy, companion diagnostic IVD, and therapeutic markets by various segments and subsegments
- Identification of key market dynamics, trends, and opportunities
- Insight into mergers and acquisitions, new product developments, strategies, and research-and-development activities
- Comprehensive profiles of major players in the market
This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic inhibitors, anti-metabolites, aromatase inhibitors and hormone receptors), geographic market segmentation of the overall market and global market share by company with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for the year 2016, as the base year, 2017 and a forecast for 2022.
Table of Contents:
- Market and Technology Background
- Breast Cancer Market Dynamics
- Market Breakdown by Technology
- Market Breakdown by Drug Class
- Market Breakdown by Region
- Regulatory Scenario
- Patent Review/New Developments
- Reimbursement Landscape
- Pipeline Analysis
Category: Market Research Publishers and RetailersCompany about: IngeniousReports provides one-stop solution platform for all technology, business, and market research dilemmas. We, at IngeniousReports, collaborate with leading global publishers of technology, business and market intelligence reports to industries, individuals and organizations with the endeavor of supporting them in making strategic and cost-effective business decisions.
For more information:Make an Inquiry about this report HERE!